Anti-3pk [3p-8-1] |
Human |
WB |
Anti-4-1BB [BBK2 ] |
Human |
antagonist, Blocking, IP, FC, IF, IHC |
Anti-A14 [BB5.2] |
Vaccinia virus |
IP, WB, IF |
Anti-AMIGO-1 [AC27] |
Mouse |
ELISA, IF, IHC |
Anti-AMIGO-1 [AC50] |
Mouse |
ELISA, IF, IHC |
Anti-ASCL1 [SC72.2] |
Human |
ELISA, IHC |
Anti-avian infectious bronchitis virus Nucleoprotein [C5P1] |
avian infectious bronchitis virus |
WB, ELISA |
Anti-Bovine Coronavirus [BCoV1/1] |
Bovine coronavirus |
EIA, neutralizing, ELISA, IF |
Anti-Bovine coronavirus [SF-3E4] |
Bovine coronavirus |
neutralising, WB, ELISA |
Anti-Bovine Herpesvirus gD [BoScFv] |
Bovine Herpesvirus-1 |
WB, Block, ELISA, IF |
Anti-Canarypox Virus [CNPV-5A11] |
Canarypox virus |
WB, ELISA, IF |
Anti-Canine Parvovirus [scFv] |
canine parvovirus |
NTRL, ELISA |
Anti-Capsid protein VP3 [VHH-12B] |
Poliovirus |
cryo EM, ELISA |
Anti-Capsid protein VP3 [VHH-7A] |
Poliovirus |
cryo EM, ELISA |
Anti-Capsid protein VP3 [VHH-7B] |
Poliovirus |
cryo EM, ELISA |
Anti-CCR5 [ST6] |
rhesus macaque, Human |
depleting, SPR, ELISA, FC |
Anti-CD205 [DEC-205] |
Mouse |
vaccination |
Anti-CD25 [7D4] |
Mouse |
depleting, FC |
Anti-CD4 [5A8] |
Human |
RIA, WB, ELISA, IHC |
Anti-CD4 [EDU-2 (B486)] |
Human |
FC, IF, IHC |
Anti-CD5 [OX-19] |
Rat |
inhibit, WB, FC, IHC |
Anti-CD81 [CD81K04] |
Human |
crystallisation, Neutralisation, FC |
Anti-Cedar virus F [19E 7] |
Cedar henipavirus (Cedar virus) |
IP, WB |
Anti-Cedar virus G [11D5] |
Cedar henipavirus (Cedar virus) |
IP |
Anti-Cedar virus G [14F3] |
Cedar henipavirus (Cedar virus) |
IP, WB |
Anti-cFos [C1-82] |
Human |
WB, ELISA, IF, IHC |
Anti-cFos [C1-84] |
Human |
WB, ELISA, IF, IHC |
Anti-cFos [C2-58] |
Human |
WB, ELISA, IF, IHC |
Anti-cFos [C2-66] |
Human |
WB, ELISA, IF, IHC |
Anti-cFos [S1-54] |
Human |
WB, ELISA, IF, IHC |
Anti-cFos [S1-71] |
Human |
WB, ELISA, IF, IHC |
Anti-CMV [EIV-15] |
Cytomegalovirus |
NTRL, ELISA |
Anti-CMV coat protein [6A1] |
Cucumber mosaic virus |
WB, ELISA |
Anti-CMV glycoprotein gB [HCMV37] |
CMV |
ICC, NTRL, ELISA, IF, IHC-Fr |
Anti-Coat protein [DDF-RuV1] |
Rubella Virus |
neutralize, ELISA |
Anti-Coat protein [DDF-RuV2] |
Rubella Virus |
neutralize, ELISA |
Anti-Covid-19 & SARS-CoV Nucleocapsid [1C7C7] |
SARS-CoV, SARS-CoV-2 |
WB, ELISA, FC, IHC |
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] |
SARS-CoV, SARS-CoV2 |
ELISA, IF |
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)] |
SARS-CoV, SARS-CoV2 |
ELISA, IF |
Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022] |
SARS-CoV-2 (COVID-19) & SARS Coronavirus |
crystallography, NTRL, SPR, ELISA, IF |
Anti-CPV capsid [A3B10 (MAb 8)] |
canine parvovirus, feline panleukopenia virus |
IP, NTRL, ELISA |
Anti-CPV capsid [Clone 2] |
canine parvovirus |
ELISA |
Anti-CymMV Coat protein [11A12F5] |
Cymbidium mosaic virus |
ELISA |
Anti-Cytomegalovirus (CMV) gH glycoprotein [MSL-109] |
CMV |
NTRL |
Anti-DENV-2 E protein [4G2] |
Dengue Virus, Flavivirus group, Zika Virus |
functional assay, ELISA, IF, IHC |
Anti-DI/DII domain of Dengue E protein [DV18] |
Dengue Virus |
NTRL, ELISA |
Anti-DI/DII domain of Dengue E protein [DV78] |
Dengue Virus |
NTRL, ELISA |
Anti-DIII domain of Dengue E protein (DENV-1 and DENV-3) [DV63] |
Dengue Virus |
NTRL, ELISA |
Anti-DIII domain of Dengue E protein [DV10] |
Dengue Virus |
NTRL, ELISA |
Anti-dsRNA [1D3] |
Virus |
WB, ELISA, IHC |
Anti-dsRNA [9D5 ] |
Virus |
WB, ELISA, IHC |
Anti-dsRNA [J2] |
Species independent |
IP, ELISA, EM, IF, IHC |
Anti-dsRNA/ssRNA [P6] |
Species independent |
fucntional assay, ELISA |
Anti-E protein [13D6] |
Tick-borne encephalitis virus |
neutralization, ELISA, IHC |
Anti-E protein [14D5] |
Tick-borne encephalitis virus |
crystallization, in vitro, in vivo, neutralization, SPR, ELISA |
Anti-E protein [Mab 4.2] |
Louping ill virus, Tick-borne encephalitis virus |
Cristallization, in vivo, neutralizing, SPR, ELISA, IF |
Anti-E protein [T025] |
Tick-borne encephalitis virus |
crystallization, in vivo, neutralizing, ELISA, IF |
Anti-E-protein DIII (ABDE) [ZV-2] |
Zika Virus |
crystallization, SPR, FC |
Anti-E-protein DIII (C-C’) [ZV-48] |
Zika Virus |
crystallization, NTRL, SPR, FC |
Anti-E-protein DIII (C-C’) [ZV-64] |
Zika Virus |
crystallization, NTRL, SPR, FC |
Anti-E-protein DIII (LR) [ZV-67] |
Zika Virus |
crystallization, NTRL, SPR, WB, FC |
Anti-E2 A domain [F5] |
Human Venezuelan Equine Encephalitis Virus |
crystallization, NTRL |
Anti-E2 B domain [3b4c-4] |
Human Venezuelan Equine Encephalitis Virus |
crystallization, NTRL, ELISA |
Anti-E2 protein [Chk265] |
Alphaviruses, Chikungunya |
crystallization, NTRL, ELISA, FC, IF |
Anti-Ebola GP [13F6-1-2] |
Ebola Virus |
functional assay, neutralizing, SPR, WB, ELISA |
Anti-Ebola GP [h-13F6] |
EBOV (Zaire) |
IP, SPR, ELISA |
Anti-Ebola Nucleoprotein [KZ51] |
Ebola Virus (Zaire, Ivory Coast, Reston, Sudan) |
IP, WB, ELISA, IF |
Anti-Ebola surface glycoprotein [KZ52] |
Ebola (Zaire) |
crystallization, IP, NTRL, IF |
Anti-Ebola virus VP35 protein; [6c5] |
Zaire ebolavirus |
IP, Western blot, IF |
Anti-Envelope glycoprotein Gc [A5] |
Hantavirus |
crystallization, SPR |
Anti-Envelope protein [ZKA64] |
Zika Virus |
enhance, NTRL, ELISA, FC |
Anti-Envelope protein [ZKA78] |
Dengue Virus, Zika Virus |
enhance, NTRL, ELISA, FC |
Anti-Envelope protein domain III [POWV-80] |
Powassan virus |
crystallography, neutralizing, ELISA, FC |
Anti-F glycoprotein [12B2] |
Nipah virus |
functional assay, neutralize |
Anti-Feline Calicivirus; [1D7] |
Feline calicivirus |
NTRL, ELISA |
Anti-FGF12/FHF1 [N94/17] |
Rat, Human, Mouse |
IP, IHC |
Anti-FGF13/FHF2 [N91/27.1] |
mouse, rat, Human |
WB |
Anti-FHV-1 [JH2] |
Feline Herpes Virus |
cat diagnostics, cat therapeutics, neutralising |
Anti-Flavivirus group antigen [D1-4G2-4-15 (4G2)] |
Dengue Virus, Flaviviridae, West Nile Virus, Yellow Fever Virus, Zika Virus |
IHC-P, NTRL, WB, ELISA, FC, IF |
Anti-GABA(B)R [N93A/49.2] |
Rat, Human, Mouse |
IP, PLA, IF |
Anti-Gephyrin [GC1] |
Human |
WB, ELISA, IF, IHC |
Anti-Gephyrin [GC52] |
Human |
WB, ELISA, IF, IHC |
Anti-Gephyrin [GC92] |
Human |
WB, ELISA, IF, IHC |
Anti-Gephyrin [GS41] |
Human |
WB, ELISA, IF, IHC |
Anti-Gephyrin [GS8] |
Human |
WB, ELISA, IF, IHC |
Anti-GFP [N86/38.1] |
Aequorea victoria |
IP, IF, IHC |
Anti-Ghana Virus F [7C11-LY] |
Ghana virus |
IP, ELISA |
Anti-Ghana Virus G [10C4-LY] |
Ghana virus |
IP, WB, ELISA |
Anti-Ghana Virus G [10D5-LY] |
Ghana virus |
IP, WB, ELISA |
Anti-Glycoprotein [MR78] |
Ebola Virus, Marburg Virus |
neutralize, ELISA |
Anti-Glycoprotein B of HSV [Fd79] |
Herpes Simplex Virus |
NTRL, FC, IF |
Anti-Glycoprotein Complex [37.7H] |
Lassa virus |
crystallography, NTRL, WB, ELISA |
Anti-Glycoprotein D of HSV [Fd138-80] |
Herpes Simplex Virus |
NTRL, FC, IF |
Anti-glycoprotein E [19/1786] |
Tick-borne encephalitis virus |
Cryo-EM, IP, Neurtalization, WB, ELISA |
Anti-Glycoprotein E1 [IGH526 (4805, 48G5C4)] |
Hepatitis C virus (HCV) |
functional assay, neutralize, ELISA, FC, IF |
Anti-Glycoprotein E2 [19B3] |
Hepatitis C virus (HCV) |
functional assay, neutralizing, ELISA |
Anti-Glycoprotein E2 [212.1.1] |
Hepatitis C virus (HCV) |
functional assay, neutralization, ELISA, FC |
Anti-Glycoprotein E2 [AP33] |
Hepatitis C virus (HCV) |
functional assay, IP, neutralize, Block, ELISA |
Anti-Glycoprotein E2 [HC-11] |
Hepatitis C virus (HCV) |
IP, neutralize, ELISA, FC, IF |
Anti-Glycoprotein E2 [HC-1AM] |
Hepatitis C virus (HCV) |
neutralize, ELISA, FC |
Anti-Glycoprotein E2 [HC33.1] |
Hepatitis C virus (HCV) |
neutralize, WB, ELISA |
Anti-Glycoprotein E2 [HC84.26.5D (HC26AM)] |
Hepatitis C virus (HCV) |
IP, neutralize, ELISA |
Anti-Glycoprotein H [A13-d6.3] |
pseudorabies virus (PrV) |
crystalize, immunostaining, neutralize |
Anti-Glycoprotein H [MAb 5] |
HCMV |
ELIS, IP, RIA |
Anti-GP1 [GD01] |
Junin virus (JUNV) |
crystallize, neutralize, ELISA |
Anti-HA [8H5] |
Influenza A Virus (several subtypes) |
Hemagglutination inhibition test;, NTRL, ELISA |
Anti-HA [AV.C4] |
H5N1 Influenza A Virus |
NTRL, WB, ELISA |
Anti-HA [AV.D1] |
H5N1 Influenza A Virus |
NTRL, ELISA |
Anti-HA [AV.G4] |
H5N1 Influenza A Virus |
WB, ELISA |
Anti-HA [CR6261] |
Influenza A Virus (several subtypes) |
NTRL, therapeutic |
Anti-HA [CR8020] |
Influenza A Virus (several subtypes) |
NTRL, therapeutic, FC |
Anti-HA [FB75] |
Influenza A Virus (several subtypes) |
NTRL, ELISA |
Anti-HA [FC41] |
Influenza A Virus (several subtypes) |
ELISA |
Anti-HA [FE17] |
Influenza A Virus (several subtypes) |
ELISA |
Anti-HAV IRES domain V [HAVx] |
Hepatitis A Virus |
ELISA |
Anti-HBeAg [E6] |
Hep B |
cross-competition assay, crystallization, Mab: RIA, serum protein electrophoresis. Fab |
Anti-HBsAg [5C3] |
Hepatitis B Virus |
RIA |
Anti-HBsAg [F124 scFv] |
Hepatitis B Virus |
ELISA |
Anti-HCMV [8F9] |
Human Cytomegalovirus |
IP, neutralize, WB, ELISA, FC |
Anti-HCMV gB [5A6] |
Human cytomegalovirus (HCMV) |
IP, Neutralisation, FC, IF |
Anti-HCMV gB [HCMV37] |
Human Cytomegalovirus |
IP, NTRL, ELISA, IF |
Anti-HCMV gH [HCMV16] |
Human Cytomegalovirus |
IP, NTRL, ELISA, IF |
Anti-HCV E1E2 complex [AR4A (N4)] |
Hepatitis C virus (HCV) |
IP, neutralize, therapeutic, ELISA, FC |
Anti-HCV IRES junction IIIabc [HCV2] |
Hepatitis C virus |
therapeutic, ELISA |
Anti-HCV NS3 Protein [Hfab-aNS3] |
Hepatitis C |
helicase assay, ICC, ELISA |
Anti-Hemagglutinin [17/9] |
Influenza A virus |
|
Anti-hemagglutinin H1 [3978] |
Influenza B virus |
functional assay, ELISA, FC |
Anti-hemagglutinin H1 [5589] |
Influenza A virus |
functional assay, ELISA, FC |
Anti-hemagglutinin H1 [7665] |
Influenza A virus |
functional assay, ELISA, FC |
Anti-hemagglutinin H3 [1664] |
Influenza A virus |
functional assay, ELISA, FC |
Anti-Hendra and Nipah virus G [48D3] |
Hendra henipavirus (Hendra virus, HeV), Nipah henipavirus (Nipah virus, NiV) |
IP, WB |
Anti-Hendra and Nipah virus G [5B1] |
Hendra henipavirus (Hendra virus, HeV), Nipah henipavirus (Nipah virus, NiV) |
IP, neutralizing |
Anti-Hendra and Nipah virus G [7B7] |
Hendra henipavirus (Hendra virus, HeV), Nipah henipavirus (Nipah virus, NiV) |
IP, neutralizing |
Anti-Hepatitis A virus capsid [R10] |
Hepatitis A Virus |
crystallisation, Neutralisation, ELISA |
Anti-His tag [4C9] |
Species independent |
epitope tag, WB, ELISA |
Anti-His tag [H343] |
Species independent |
epitope tag, Purification, ELISA |
Anti-His tag [H7219] |
Species independent |
epitope tag, Purification, ELISA |
Anti-HIV capsid protein p24 [13B5] |
HIV |
SPR, ELISA |
Anti-HIV capsid protein p24 [CB4-1] |
HIV |
ELISA |
Anti-HIV GP41 [2E7 (L92E7)] |
HIV-1 |
NTRL, ELISA |
Anti-HIV-1 GP120 [0.5B] |
HIV-1 |
IP, NTRL, FC |
Anti-HIV-1 gp120 [447-D] |
HIV-1 (Human immunodeficiency virus 1) |
functional assays, neutralizing, WB, ELISA, IF |
Anti-HIV-1 gp120 [694-D] |
HIV-1 (Human immunodeficiency virus 1) |
functional assays, neutralizing, WB, ELISA, IF |
Anti-HIV-1 GP120 [b12 (MT12)] |
HIV-1 |
neutralize, therapeutic, ELISA |
Anti-HIV-1 GP120 [HGD65] |
HIV-1 |
NTRL |
Anti-HIV-1 GP120 [HGN194] |
HIV-1 |
NTRL |
Anti-HIV-1 GP120 [HGZ1] |
HIV-1 |
NTRL |
Anti-HIV-1 GP120 [HJ16] |
HIV-1 |
NTRL |
Anti-HIV-1 GP120 [HR10] |
HIV-1 |
NTRL |
Anti-HIV-1 GP120 [HR12] |
HIV-1 |
NTRL |
Anti-HIV-1 GP120 [PGT124] |
HIV-1 |
functional assay, neutralize, ELISA |
Anti-HIV-1 GP120 [VRC03] |
HIV-1 |
neutralize, SPR, ELISA |
Anti-HIV-1 GP120 [X5] |
HIV-1 |
functional assay, neutralization, WB, ELISA, FC |
Anti-HIV-1 GP120 [YZ18] |
HIV-1 |
ELISA, NTRL |
Anti-HIV-1 GP120 [YZ23] |
HIV-1 |
ELISA, NTRL |
Anti-HIV-1 GP41 [HGF24] |
HIV-1 |
NTRL |
Anti-HIV-1 GP41 [HK20] |
HIV-1 |
NTRL |
Anti-HN Protein [1A6] |
Sendai Virus |
Hemagglutination inhibition, Neutralisation, IF |
Anti-HPV16E6 & HPV18E6 [C1P5] |
Human papilloma virus |
IP, WB, IHC |
Anti-HSV-1 VP5 [6F10-D2-G2] |
Herpes simplex |
functional assays, IP, WB, ELISA, IF |
Anti-Human Rhinovirus 14 [Fab17-IA] |
Human Rhinovirus 14 |
Neutralize; |
Anti-iC3b [5D2] |
Human, Mouse |
IP, ELISA, IHC |
Anti-IFNa 2b [scFv 17] |
Human |
ELISA |
Anti-IFNA 8 [α8#139] |
Human |
Immunoaffinity chromatography, NTRL, RIA, WB, ELISA |
Anti-IFNA 8 [α8Y36-2] |
Human |
RIA, WB, ELISA |
Anti-IFNAR-1 [64G12] |
Human |
confocal microscopy, inhibit, IP, NTRL, WB, ELISA, FC, IF |
Anti-infectious bursal disease virus [CRAb154] |
infectious bursal disease virus |
IP, ELISA |
Anti-infectious bursal disease virus VP2 [CRAb 88] |
very virulent infectious bursal disease virus (CS89) |
IP, ELISA |
Anti-influenza [2-8C] |
Influenza A virus nucleoprotein (NP) |
neutralisation assays, virus titration/quantification, WB, ELISA, IF, IHC |
Anti-influenza [2-12C] |
Influenza A virus hemagglutinin glycoprotein (HA) |
hemagglutination inhibition test, microneutralization assays, virus titration, ELISA, IF |
Anti-influenza [3-10B] |
Influenza B virus nucleoprotein (NP) |
neutralisation assays |
Anti-influenza [T1-3B] |
Influenza A virus hemagglutinin glycoprotein (HA) |
hemagglutination inhibition test, microneutralization assays, virus titration, ELISA, IF |
Anti-Influenza A HA [FLD127] |
H5N1 Influenza A Virus |
NTRL, RIA, ELISA |
Anti-Influenza A HA [FLD20] |
H5N1 Influenza A Virus |
NTRL |
Anti-Influenza A HA [FLD21] |
H5N1 Influenza A Virus |
NTRL |
Anti-Influenza A HA [FLD84] |
H5N1 Influenza A Virus |
NTRL, RIA, ELISA |
Anti-Influenza A HA [FLD93] |
H5N1 Influenza A Virus |
NTRL |
Anti-Influenza A HA [HA] |
Influenza A Virus (several subtypes) |
ELISA |
Anti-Influenza A nucleoprotein [aNP-VHH1] |
Influenza A |
crystallography, IP, EM, FC |
Anti-Influenza A virus NS1 [NS1-23-1] |
Influenza A virus |
IP, WB |
Anti-JEV virions (E/PrM) [TJE12B02] |
Japanese Encephalitis Virus |
IP, NTRL, ELISA |
Anti-La Crosse virus, G1 envelope glycoprotein [807.15] |
La Crosse Bunyavirus |
IP, neutralising assays, viral serology, WB, ELISA, FC |
Anti-La Crosse virus, G1 envelope glycoprotein [807.31] |
La Crosse Bunyavirus |
IP, neutralising assays, viral serology, WB, ELISA, FC |
Anti-LAM [CS-35] |
Mycobacterium leprae, Mycobacterium tuberculosis, Mycobacterium bovis |
ELISA;, WB, FC, IF |
Anti-LDL receptor [12G4] |
Hamster, Rat, Human, Mouse |
Block, ELISA, FC, IHC |
Anti-LMP1 [S12] |
Epstein-Barr virus |
IB, IP, WB, ELISA, FC, IHC |
Anti-LMP2A [14B7] |
Epstein-Barr virus |
IB, IP, WB, ELISA, IF |
Anti-M13 bacteriophage [E1] |
M13 phage |
WB, ELISA, FC, IHC |
Anti-Malin [N85/18.1] |
Human |
IP, WB, IHC |
Anti-Marburg virus nucleoprotein [sdAb 4] |
Marburg virus (MARV) |
cross-linking, crystallography, ELISA |
Anti-Matrix Protein [E10] |
Influenza A virus |
WB, ELISA, FC, IHC |
Anti-MERS-CoV Spike protein [1F8] |
MERS Coronavirus |
NTRL |
Anti-MERS-CoV Spike protein [3A1] |
MERS Coronavirus |
NTRL |
Anti-MERS-CoV Spike protein [3B12] |
MERS Coronavirus |
NTRL |
Anti-MERS-CoV Spike Protein [4c2] |
MERS-CoV |
crystallization, NTRL, ELISA |
Anti-MERS-CoV Spike protein [M14D3] |
MERS Coronavirus |
NTRL |
Anti-MESD [N88/12.1] |
Rat, Human, Mouse |
IP, WB, IHC |
Anti-Mojiang Virus F [3C4-LY] |
Mojiang henipavirus (Mojiang virus, MojV) |
IP, ELISA |
Anti-Mojiang Virus F [4G5-LY] |
Mojiang henipavirus (Mojiang virus, MojV) |
IP, WB, ELISA |
Anti-Mojiang Virus G [10G2-LY] |
Mojiang henipavirus (Mojiang virus, MojV) |
IP, ELISA |
Anti-Mojiang Virus G [6E5-LY] |
Mojiang henipavirus (Mojiang virus, MojV) |
IP, ELISA |
Anti-Monkeypox Virus [VACV-5C7] |
Monkeypox virus |
ELISA, IF |
Anti-Murine leukemia virus p30 gag capsid polypeptide [R187] |
Murine leukemia virus |
IP, IF |
Anti-N9 Neuraminidase [NC41 ] |
Influenza |
crystallisation |
Anti-Neutralizing Epitope [ZKA185] |
Zika Virus |
NTRL |
Anti-Nipah and Hendra G [nAH1.3] |
Hendra virus, Nipah virus |
neutralizing |
Anti-Nipah virus F F1 [5G7] |
Nipah henipavirus (Nipah virus, NiV) |
IP, WB |
Anti-Nipah virus F F2 [11F10] |
Nipah henipavirus (Nipah virus, NiV) |
IP, WB |
Anti-Nipah virus F F2 [6D3] |
Nipah henipavirus (Nipah virus, NiV) |
IP, WB |
Anti-Nipah virus F Site I [16C2] |
Nipah henipavirus (Nipah virus, NiV) |
IP |
Anti-Nipah virus F Site II [4C9] |
Nipah henipavirus (Nipah virus, NiV) |
IP |
Anti-Nipah virus F Site IV [1E 11] |
Nipah henipavirus (Nipah virus, NiV) |
IP |
Anti-Nipah virus F1 [13G5] |
Nipah henipavirus (Nipah virus, NiV) |
IP, WB |
Anti-Norovirus capsid protein VP1 [A1227] |
Norovirus |
ELISA |
Anti-Norovirus GII.4 [NVB43.9] |
Norovirus |
NTRL, Block |
Anti-Norovirus GII.4 P domain [A1431] |
Norovirus |
neutralize, Block, ELISA |
Anti-Norovirus GII.4 VP1 [8E1] |
Norovirus |
neutralize, ELISA |
Anti-Norovirus P domain [Nano-27] |
Norovirus |
crystallography, ITC, neutralisation assay, ELISA |
Anti-Norovirus P domain [Nano-4] |
Norovirus |
crystallography, ITC, neutralisation assay, ELISA |
Anti-Notch 1 [WC613] |
Human |
IP, ELISA, FC |
Anti-Notch 1 [WC75] |
Human |
IP, ELISA, FC |
Anti-NP [JS08] |
SARS-CoV-2 |
SPR, WB, ELISA |
Anti-NP [JS16] |
SARS-CoV-2 |
SPR, WB, ELISA |
Anti-NS1 [22NS1 ] |
West Nile Virus |
crystallography, NTRL, FC |
Anti-NS1 [ZKA35] |
Zika Virus |
Blockade-of-Binding ELISA, BOB ELISA, Competition ELISA, ELISA |
Anti-Orthopoxviruses [VACV-5B1] |
Orthopoxviruses |
Immunogold electron microscopy, IP, WB, ELISA, FC, IF |
Anti-p35 protein of Orthopoxvirus [1A] |
Orthopoxvirus |
WB, ELISA |
Anti-Parvovirus [MAbE] |
canine parvovirus, feline panleukopenia virus |
IP, Neutralisation, RIA, ELISA, EM |
Anti-peptides (neutralizing epitope) [Clone 36] |
Influenza A (H3N2) |
ELISA |
Anti-PERV [7C4] |
Porcine Endogenous Retrovirus |
neutralize, WB, ELISA |
Anti-PERV [A5] |
Porcine Endogenous Retrovirus |
WB |
Anti-PERV p27 [D2] |
Porcine Endogenous Retrovirus |
WB |
Anti-Poxvirus L1 Protein [Fab 7d11] |
Poxviruses |
crystallization, PRNT, ELISA |
Anti-pre- and post-fusion conformation of HRSV F protein [RSB15] |
Respiratory Syncytial Virus (RSV) |
NTRL, IF |
Anti-pre- and post-fusion conformation of HRSV F protein [RSB16] |
Respiratory Syncytial Virus (RSV) |
NTRL, IF |
Anti-pre-fusion conformation of HRSV F protein [RSB20] |
Respiratory Syncytial Virus (RSV) |
NTRL, IF |
Anti-pre-fusion conformation of HRSV F protein [RSB43] |
Respiratory Syncytial Virus (RSV) |
NTRL, IF |
Anti-PRSV coat protein [9G2D3] |
Papaya ringspot virus |
ELISA |
Anti-Rabies Virus 67kDa protein [EP5G3] |
Rabies Virus |
IP, NTRL, WB, ELISA |
Anti-Rabies Virus 67kDa protein [Fab094] |
Rabies Virus |
IP, NTRL, WB, ELISA |
Anti-Rabies Virus 67kDa protein [GD2D12] |
Rabies Virus |
IP, NTRL, WB, ELISA |
Anti-Rabies Virus Glycoprotein [A11] |
Rabies virus (Pasteur strain) |
WB, ELISA |
Anti-Rabies Virus Glycoprotein [C12] |
Rabies virus (CVS-11) |
ELISA |
Anti-Rabies Virus Glycoprotein [R16E5] |
Rabies Virus |
NTRL, WB, ELISA |
Anti-RRV E2 [D7] |
Ross River Virus |
labelling, FC |
Anti-RSV [RSHZ19 (Felvizumab)] |
RSV |
functional, ELISA |
Anti-RSV G protein [131-2G] |
Respiratory Syncytial Virus (RSV) |
therapeutic, ELISA |
Anti-RSV G protein [CB002.5] |
Respiratory Syncytial Virus (RSV) |
neutralize, ELISA |
Anti-S protein (RBD) [STE90-C11] |
SARS-CoV-2 |
biolayer interferometry, crystallography, in vitro inhibition, in vitro neutralization, in vivo protection, therapeutic, ELISA |
Anti-S2 domain [S2A3] |
MERS |
SPR, ELISA, IF |
Anti-Saint Louis encephalitis virus envelope glycoprotein [6B6C-1] |
Saint Louis encephalitis virus |
immunoblot, IP, ELISA |
Anti-SAPAP2 [SS88] |
Rat |
WB, ELISA, IF, IHC |
Anti-SARS-CoV Nucleoprotein [N18] |
SARS Coronavirus |
ELISA |
Anti-SARS-CoV S glycoprotein [11A] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [1B5] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [256] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [4D4] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [4G2] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [4S1] |
SARS Coronavirus |
ELISA, IF |
Anti-SARS-CoV S glycoprotein [5D3] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [5E4] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [6B1] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [A11] |
SARS Coronavirus |
WB, ELISA, IF |
Anti-SARS-CoV S glycoprotein [F26G10] |
SARS Coronavirus |
NTRL, ELISA, IF |
Anti-SARS-CoV S glycoprotein [F26G19] |
SARS Coronavirus |
NTRL, WB, ELISA, IF |
Anti-SARS-CoV S glycoprotein [F26G9] |
SARS Coronavirus |
NTRL, ELISA, IF |
Anti-SARS-CoV S glycoprotein [Lsc18] |
SARS Coronavirus |
WB, ELISA, IF |
Anti-SARS-CoV S glycoprotein [S109] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S110] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S124] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S215] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S217] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S222] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S223] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S225] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S226] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S227] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S228] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S230] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [S231] |
SARS Coronavirus |
NTRL, ELISA |
Anti-SARS-CoV S glycoprotein [Ssc35] |
SARS Coronavirus |
WB, ELISA, IF |
Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17] |
SARS Coronavirus |
WB, ELISA, IF |
Anti-SARS-CoV-2 nucleocapsid [mBG86] |
SARS-CoV-2 |
WB, ELISA, IF |
Anti-SARS-CoV-2 Spike protein (RBD monomer) [2B-E7-C9] |
SARS Coronavirus 2 (SARS-Cov-2) |
ELISA |
Anti-SARS-CoV-2 Spike protein (RBD monomer) [2B-G10-A1] |
SARS Coronavirus 2 (SARS-Cov-2) |
ELISA |
Anti-SEB [6D3] |
Staphylococcus aureus |
ELISA, WB, Inhibit, Block |
Anti-Spike protein [EY6A] |
SARS Coronavirus 2 (SARS-Cov-2) |
NTRL, Surface Plasmon Resonance, therapeutic, ELISA, IF |
Anti-Spike protein [MR17 ] |
SARS Coronavirus 2 (SARS-Cov-2) |
biolayer interferometry, FACS, NTRL, therapeutic, ELISA |
Anti-Spike protein [MR3] |
SARS Coronavirus 2 (SARS-Cov-2) |
biolayer interferometry, FACS, NTRL, therapeutic, ELISA |
Anti-Spike protein [Sb23] |
SARS Coronavirus 2 (SARS-Cov-2) |
biolayer interferometry, NTRL, ELISA |
Anti-Spike protein [SR4] |
SARS Coronavirus 2 (SARS-Cov-2) |
biolayer interferometry, FACS, NTRL, therapeutic, ELISA |
Anti-Spike protein [Ty1] |
SARS Coronavirus 2 (SARS-Cov-2) |
biolayer interferometry, inhibit, NTRL, ELISA, FC, IF |
Anti-Spike Protein (RBD) [CV30] |
SARS Coronavirus 2 |
neutralize, therapeutic, ELISA, FC |
Anti-Spike protein (RBD) [Sb#14] |
SARS Coronavirus 2 (SARS-Cov-2) |
grating-coupled interferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) [Sb#15] |
SARS Coronavirus 2 (SARS-Cov-2) |
grating-coupled interferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) [Sb#16] |
SARS Coronavirus 2 (SARS-Cov-2) |
grating-coupled interferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) [Sb#42] |
SARS Coronavirus 2 (SARS-Cov-2) |
grating-coupled interferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) [Sb#45] |
SARS Coronavirus 2 (SARS-Cov-2) |
grating-coupled interferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein (RBD) [Sb#68] |
SARS Coronavirus 2 (SARS-Cov-2) |
grating-coupled interferometry, inhibition, therapeutics, ELISA |
Anti-Spike protein [18F4] |
SARS Coronavirus 2 (SARS-Cov-2) |
functional assay, SPR, Block, ELISA |
Anti-Spike protein [4A8] |
SARS Coronavirus 2 (SARS-Cov-2) |
functional assay, neutralizing, ELISA, FC |
Anti-Spike Protein [CV1] |
SARS Coronavirus 2 |
neutralize, therapeutic, ELISA, FC |
Anti-Spike protein [D70678-5521-S2] |
SARS Coronavirus 2 (SARS-Cov-2) |
functional assay, SPR, ELISA |
Anti-Tetanus toxoid [F13] |
Clostridium tetani |
NTRL, WB, ELISA |
Anti-TGEV Coronavirus Spike glycoprotein [1AF10] |
TGEV coronavirus |
NTRL, RIA, WB, ELISA |
Anti-V5 epitope tag [SV5-P-K] |
Paramyxovirus Simian Virus 5 |
IP, RIA, WB, ELISA, IF, IHC-Fr |
Anti-Vaccinia A13 protein [11F7] |
Monkeypox virus, Orthopoxvirus, Vaccinia virus, variola virus |
neutralize, SPR, WB, ELISA, IF |
Anti-Vaccinia A33 glycoprotein [A2C7] |
Vaccinia virus |
neutralization, IF |
Anti-Vesicular stomatitis virus nucleoprotein N [VHH-1004] |
Vesicular stomatitis virus (VSV) |
LUMIER assays, transcription assays, FC |
Anti-VP1 protein [EBB-C1975-B5] |
BK virus, Human polyomavirus 1 |
NTRL, ELISA |
Anti-VP1 protein [NEG447A] |
BK virus, Human polyomavirus 1 |
ELISA |
Anti-VP2 [8F5] |
Human rhinovirus type 2 |
NTRL, WB, IP, IHC |
Anti-VP35 [H3] |
Marburg Virus |
crystallography, inhibition, ELISA |
Anti-VSV-M [23H12] |
Vesicular stomatitis Indiana virus |
WB, IF |
Anti-VSV-N [10G4] |
Vesicular stomatitis Indiana virus |
WB |
Anti-WNV Envelope protein [9E2] |
West Nile Virus |
NTRL, WB |
Anti-WNV Envelope protein DI-DII [E53] |
West Nile Virus |
crystallography, NTRL |
Anti-Yellow Fever Virus [2D12] |
Yellow Fever Virus |
functional assay, RIA, ELISA, FC, IF |
Anti-ZIKV E domain II [SMZAb2] |
Zika Virus |
neutralisation assays, therapeutic, ELISA |
Anti-ZIKV E domain III [SMZAb1] |
Zika Virus |
neutralisation assays, therapeutic, ELISA |
Anti-ZIKV E domain III [SMZAb5] |
Zika Virus |
neutralisation assays, therapeutic, ELISA |
Anti-ZIKV E domain III [Z004] |
DENV1 virus, Zika Virus |
crystallography, neutralisation assays, ELISA |
Anti-ZIKV soluble envelope protein [z23] |
Zika Virus |
Block |